Erlotinib News and Research

RSS
Erlotinib is a drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. Erlotinib is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, OSI-774, and Tarceva.
UC San Diego researchers identify new therapeutic approach to kill cancer cells

UC San Diego researchers identify new therapeutic approach to kill cancer cells

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

New cell co-culture platform holds promise for future of personalized medicine

New cell co-culture platform holds promise for future of personalized medicine

Tobacco use causes precancerous cells to 'fertilize' nearby cells with cancerous changes

Tobacco use causes precancerous cells to 'fertilize' nearby cells with cancerous changes

Blood-based liquid biopsies can accurately track cancer treatment responses

Blood-based liquid biopsies can accurately track cancer treatment responses

Physicians more likely to prescribe drugs of manufacturers who paid them money

Physicians more likely to prescribe drugs of manufacturers who paid them money

Toxic effects of drugs in the lungs 'more widespread than thought'

Toxic effects of drugs in the lungs 'more widespread than thought'

Raman microscopy can help detect cancer drug resistance

Raman microscopy can help detect cancer drug resistance

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Scientists uncover new way to make cancers sensitive to treatment

Scientists uncover new way to make cancers sensitive to treatment

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

New study finds enhanced impact of drug combination for FAP patients

New study finds enhanced impact of drug combination for FAP patients

UCLA scientists discover potential combination treatment for brain cancer in adults

UCLA scientists discover potential combination treatment for brain cancer in adults

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

New blood test can accurately, quickly identify genetic mutations linked to NSCLC

New blood test can accurately, quickly identify genetic mutations linked to NSCLC

Researchers propose novel theory of how some cancers circumvent killing power of targeted therapies

Researchers propose novel theory of how some cancers circumvent killing power of targeted therapies

Penn studies provide new understanding of lung cancer progression and prevention

Penn studies provide new understanding of lung cancer progression and prevention

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit